Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 18 entries
Sorted by: Best Match Show Resources per page
[Initial clinical experience with digital x-ray television using a CCD matrix camera].

Radiologia diagnostica

Zur C, Beuthan J, Anders W, Scheibler C.
PMID: 3775019
Radiol Diagn (Berl). 1986;27(4):537-43.

No abstract available.

Cite
Zur C, Beuthan J, Anders W, et al. Erste klinische Erprobung des digitalen Röntgenfernsehens mit einer CCD-Matrix-Kamera. [Initial clinical experience with digital x-ray television using a CCD matrix camera]. Radiol Diagn (Berl). 1986;27(4):537-43
Zur, C., Beuthan, J., Anders, W., & Scheibler, C. (1986). Erste klinische Erprobung des digitalen Röntgenfernsehens mit einer CCD-Matrix-Kamera. [Initial clinical experience with digital x-ray television using a CCD matrix camera]. Radiologia diagnostica, 27(4), 537-43.
Zur, C, et al. "Erste klinische Erprobung des digitalen Röntgenfernsehens mit einer CCD-Matrix-Kamera." [Initial clinical experience with digital x-ray television using a CCD matrix camera]. Radiologia diagnostica vol. 27,4 (1986): 537-43.
Zur C, Beuthan J, Anders W, Scheibler C. Erste klinische Erprobung des digitalen Röntgenfernsehens mit einer CCD-Matrix-Kamera. [Initial clinical experience with digital x-ray television using a CCD matrix camera]. Radiol Diagn (Berl). 1986;27(4):537-43. German. PMID: 3775019.
Copy Download .nbib Format: NLM
Large-Scale Point-Cloud Visualization through Localized Textured Surface Reconstruction.

IEEE transactions on visualization and computer graphics

Arikan M, Preiner R, Scheiblauer C, Jeschke S, Wimmer M.
PMID: 26357377
IEEE Trans Vis Comput Graph. 2014 Sep;20(9):1280-92. doi: 10.1109/TVCG.2014.2312011.

In this paper, we introduce a novel scene representation for the visualization of large-scale point clouds accompanied by a set of high-resolution photographs. Many real-world applications deal with very densely sampled point-cloud data, which are augmented with photographs that...

Cite
Arikan M, Preiner R, Scheiblauer C, et al. Large-Scale Point-Cloud Visualization through Localized Textured Surface Reconstruction. IEEE Trans Vis Comput Graph. 2014;20(9):1280-92doi: 10.1109/TVCG.2014.2312011.
Arikan, M., Preiner, R., Scheiblauer, C., Jeschke, S., & Wimmer, M. (2014). Large-Scale Point-Cloud Visualization through Localized Textured Surface Reconstruction. IEEE transactions on visualization and computer graphics, 20(9), 1280-92. https://doi.org/10.1109/TVCG.2014.2312011
Arikan, Murat, et al. "Large-Scale Point-Cloud Visualization through Localized Textured Surface Reconstruction." IEEE transactions on visualization and computer graphics vol. 20,9 (2014): 1280-92. doi: https://doi.org/10.1109/TVCG.2014.2312011
Arikan M, Preiner R, Scheiblauer C, Jeschke S, Wimmer M. Large-Scale Point-Cloud Visualization through Localized Textured Surface Reconstruction. IEEE Trans Vis Comput Graph. 2014 Sep;20(9):1280-92. doi: 10.1109/TVCG.2014.2312011. PMID: 26357377.
Copy Download .nbib Format: NLM
Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C.
PMID: 34920374
J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04.

BACKGROUND: Antibody detection of SARS-CoV-2 requires an understanding of its variation, course, and duration.METHODS: Antibody response to SARS-CoV-2 was evaluated over 5-430 days on 828 samples across COVID-19 severity levels, for total antibody (TAb), IgG, IgA, IgM, neutralizing antibody...

Cite
Scheiblauer H, Nübling CM, Wolf T, et al. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021;146:105052doi: 10.1016/j.jcv.2021.105052.
Scheiblauer, H., Nübling, C. M., Wolf, T., Khodamoradi, Y., Bellinghausen, C., Sonntagbauer, M., Esser-Nobis, K., Filomena, A., Mahler, V., Maier, T. J., & Stephan, C. (2021). Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105052. https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer, Heinrich, et al. "Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2021): 105052. doi: https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04. PMID: 34920374; PMCID: PMC8642248.
Copy Download .nbib Format: NLM
Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C.
PMID: 34920374
J Clin Virol. 2022 Jan;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04.

BACKGROUND: Antibody detection of SARS-CoV-2 requires an understanding of its variation, course, and duration.METHODS: Antibody response to SARS-CoV-2 was evaluated over 5-430 days on 828 samples across COVID-19 severity levels, for total antibody (TAb), IgG, IgA, IgM, neutralizing antibody...

Cite
Scheiblauer H, Nübling CM, Wolf T, et al. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021;146:105052doi: 10.1016/j.jcv.2021.105052.
Scheiblauer, H., Nübling, C. M., Wolf, T., Khodamoradi, Y., Bellinghausen, C., Sonntagbauer, M., Esser-Nobis, K., Filomena, A., Mahler, V., Maier, T. J., & Stephan, C. (2022). Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105052. https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer, Heinrich, et al. "Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2022): 105052. doi: https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2022 Jan;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04. PMID: 34920374; PMCID: PMC8642248.
Copy Download .nbib Format: NLM
Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C.
PMID: 34920374
J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04.

BACKGROUND: Antibody detection of SARS-CoV-2 requires an understanding of its variation, course, and duration.METHODS: Antibody response to SARS-CoV-2 was evaluated over 5-430 days on 828 samples across COVID-19 severity levels, for total antibody (TAb), IgG, IgA, IgM, neutralizing antibody...

Cite
Scheiblauer H, Nübling CM, Wolf T, et al. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021;146:105052doi: 10.1016/j.jcv.2021.105052.
Scheiblauer, H., Nübling, C. M., Wolf, T., Khodamoradi, Y., Bellinghausen, C., Sonntagbauer, M., Esser-Nobis, K., Filomena, A., Mahler, V., Maier, T. J., & Stephan, C. (2021). Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105052. https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer, Heinrich, et al. "Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2021): 105052. doi: https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04. PMID: 34920374; PMCID: PMC8642248.
Copy Download .nbib Format: NLM
[Safety of blood and blood products: test methods for the detection of hepatitis B, C, and E virus].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

Mitterreiter J, Scheiblauer H, Fiedler S, Kreß J.
PMID: 35024894
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Jan 13; doi: 10.1007/s00103-021-03480-0. Epub 2022 Jan 13.

Infections with hepatitis B, C, and E virus (HBV, HCV, and HEV) can be transmitted via blood and cause severe acute or chronic liver infections. To ensure the safety of blood donations and protect recipients from virus transmissions, blood...

Cite
Mitterreiter J, Scheiblauer H, Fiedler S, et al. Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E. [Safety of blood and blood products: test methods for the detection of hepatitis B, C, and E virus]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;doi: 10.1007/s00103-021-03480-0.
Mitterreiter, J., Scheiblauer, H., Fiedler, S., & Kreß, J. (2022). Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E. [Safety of blood and blood products: test methods for the detection of hepatitis B, C, and E virus]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, . https://doi.org/10.1007/s00103-021-03480-0
Mitterreiter, Johanna, et al. "Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E." [Safety of blood and blood products: test methods for the detection of hepatitis B, C, and E virus]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz vol. (2022). doi: https://doi.org/10.1007/s00103-021-03480-0
Mitterreiter J, Scheiblauer H, Fiedler S, Kreß J. Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E. [Safety of blood and blood products: test methods for the detection of hepatitis B, C, and E virus]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Jan 13; doi: 10.1007/s00103-021-03480-0. Epub 2022 Jan 13. German. PMID: 35024894.
Copy Download .nbib Format: NLM
Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C.
PMID: 34920374
J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04.

BACKGROUND: Antibody detection of SARS-CoV-2 requires an understanding of its variation, course, and duration.METHODS: Antibody response to SARS-CoV-2 was evaluated over 5-430 days on 828 samples across COVID-19 severity levels, for total antibody (TAb), IgG, IgA, IgM, neutralizing antibody...

Cite
Scheiblauer H, Nübling CM, Wolf T, et al. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021;146:105052doi: 10.1016/j.jcv.2021.105052.
Scheiblauer, H., Nübling, C. M., Wolf, T., Khodamoradi, Y., Bellinghausen, C., Sonntagbauer, M., Esser-Nobis, K., Filomena, A., Mahler, V., Maier, T. J., & Stephan, C. (2021). Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105052. https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer, Heinrich, et al. "Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2021): 105052. doi: https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04. PMID: 34920374.
Copy Download .nbib Format: NLM
Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C.
PMID: 34920374
J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04.

BACKGROUND: Antibody detection of SARS-CoV-2 requires an understanding of its variation, course, and duration.METHODS: Antibody response to SARS-CoV-2 was evaluated over 5-430 days on 828 samples across COVID-19 severity levels, for total antibody (TAb), IgG, IgA, IgM, neutralizing antibody...

Cite
Scheiblauer H, Nübling CM, Wolf T, et al. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021;146:105052doi: 10.1016/j.jcv.2021.105052.
Scheiblauer, H., Nübling, C. M., Wolf, T., Khodamoradi, Y., Bellinghausen, C., Sonntagbauer, M., Esser-Nobis, K., Filomena, A., Mahler, V., Maier, T. J., & Stephan, C. (2021). Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105052. https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer, Heinrich, et al. "Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2021): 105052. doi: https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04. PMID: 34920374; PMCID: PMC8642248.
Copy Download .nbib Format: NLM
[A new protective circuit for roentgen tubes].

Radiologia diagnostica

Beuthan J, Scheibler C, Müller T.
PMID: 6505214
Radiol Diagn (Berl). 1984;25(5):637-40.

No abstract available.

Cite
Beuthan J, Scheibler C, Müller T. Eine neuartige Röntgenröhrenschutzschaltung. [A new protective circuit for roentgen tubes]. Radiol Diagn (Berl). 1984;25(5):637-40
Beuthan, J., Scheibler, C., & Müller, T. (1984). Eine neuartige Röntgenröhrenschutzschaltung. [A new protective circuit for roentgen tubes]. Radiologia diagnostica, 25(5), 637-40.
Beuthan, J, et al. "Eine neuartige Röntgenröhrenschutzschaltung." [A new protective circuit for roentgen tubes]. Radiologia diagnostica vol. 25,5 (1984): 637-40.
Beuthan J, Scheibler C, Müller T. Eine neuartige Röntgenröhrenschutzschaltung. [A new protective circuit for roentgen tubes]. Radiol Diagn (Berl). 1984;25(5):637-40. German. PMID: 6505214.
Copy Download .nbib Format: NLM
Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings.

PeerJ

Schedlbauer C, Blaue D, Gericke M, Blüher M, Starzonek J, Gittel C, Brehm W, Vervuert I.
PMID: 31211018
PeerJ. 2019 Jun 07;7:e7069. doi: 10.7717/peerj.7069. eCollection 2019.

BACKGROUND: Non-alcoholic fatty liver disease is known as determining part of human obesity. The impact of body weight (BW) gain on liver metabolism has not been extensively investigated yet.OBJECTIVES: To investigate hepatic alterations caused by increasing BW in ponies...

Cite
Schedlbauer C, Blaue D, Gericke M, et al. Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings. PeerJ. 2019;7:e7069doi: 10.7717/peerj.7069.
Schedlbauer, C., Blaue, D., Gericke, M., Blüher, M., Starzonek, J., Gittel, C., Brehm, W., & Vervuert, I. (2019). Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings. PeerJ, 7e7069. https://doi.org/10.7717/peerj.7069
Schedlbauer, Carola, et al. "Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings." PeerJ vol. 7 (2019): e7069. doi: https://doi.org/10.7717/peerj.7069
Schedlbauer C, Blaue D, Gericke M, Blüher M, Starzonek J, Gittel C, Brehm W, Vervuert I. Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings. PeerJ. 2019 Jun 07;7:e7069. doi: 10.7717/peerj.7069. eCollection 2019. PMID: 31211018; PMCID: PMC6557249.
Copy Download .nbib Format: NLM
Comparison of incisional complications between skin closures using a simple continuous or intradermal pattern: a pilot study in horses undergoing ventral median celiotomy.

PeerJ

Scharner D, Gittel C, Winter K, Blaue D, Schedlbauer C, Vervuert I, Brehm W.
PMID: 30430040
PeerJ. 2018 Nov 09;6:e5772. doi: 10.7717/peerj.5772. eCollection 2018.

BACKGROUND: Development of incisional complications following ventral median celiotomy might depend on suture pattern for skin closure.METHODS: In this prospective study, 21 healthy male horses underwent celiotomy. Skin closure was either performed via a continuous percutaneous pattern (CO group;...

Cite
Scharner D, Gittel C, Winter K, et al. Comparison of incisional complications between skin closures using a simple continuous or intradermal pattern: a pilot study in horses undergoing ventral median celiotomy. PeerJ. 2018;6:e5772doi: 10.7717/peerj.5772.
Scharner, D., Gittel, C., Winter, K., Blaue, D., Schedlbauer, C., Vervuert, I., & Brehm, W. (2018). Comparison of incisional complications between skin closures using a simple continuous or intradermal pattern: a pilot study in horses undergoing ventral median celiotomy. PeerJ, 6e5772. https://doi.org/10.7717/peerj.5772
Scharner, Doreen, et al. "Comparison of incisional complications between skin closures using a simple continuous or intradermal pattern: a pilot study in horses undergoing ventral median celiotomy." PeerJ vol. 6 (2018): e5772. doi: https://doi.org/10.7717/peerj.5772
Scharner D, Gittel C, Winter K, Blaue D, Schedlbauer C, Vervuert I, Brehm W. Comparison of incisional complications between skin closures using a simple continuous or intradermal pattern: a pilot study in horses undergoing ventral median celiotomy. PeerJ. 2018 Nov 09;6:e5772. doi: 10.7717/peerj.5772. eCollection 2018. PMID: 30430040; PMCID: PMC6231425.
Copy Download .nbib Format: NLM
Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C.
PMID: 34920374
J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04.

BACKGROUND: Antibody detection of SARS-CoV-2 requires an understanding of its variation, course, and duration.METHODS: Antibody response to SARS-CoV-2 was evaluated over 5-430 days on 828 samples across COVID-19 severity levels, for total antibody (TAb), IgG, IgA, IgM, neutralizing antibody...

Cite
Scheiblauer H, Nübling CM, Wolf T, et al. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021;146:105052doi: 10.1016/j.jcv.2021.105052.
Scheiblauer, H., Nübling, C. M., Wolf, T., Khodamoradi, Y., Bellinghausen, C., Sonntagbauer, M., Esser-Nobis, K., Filomena, A., Mahler, V., Maier, T. J., & Stephan, C. (2021). Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 146105052. https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer, Heinrich, et al. "Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design." Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology vol. 146 (2021): 105052. doi: https://doi.org/10.1016/j.jcv.2021.105052
Scheiblauer H, Nübling CM, Wolf T, Khodamoradi Y, Bellinghausen C, Sonntagbauer M, Esser-Nobis K, Filomena A, Mahler V, Maier TJ, Stephan C. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design. J Clin Virol. 2021 Dec 04;146:105052. doi: 10.1016/j.jcv.2021.105052. Epub 2021 Dec 04. PMID: 34920374; PMCID: PMC8642248.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 18 entries